# Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity

> **NCT03003572** · — · RECRUITING · sponsor: **Centre Hospitalier Universitaire de Saint Etienne** · enrollment: 185 (estimated)

## Conditions studied

- Primary Sjögren's Syndrome

## Interventions

- **OTHER:** Blood samples

## Key facts

- **NCT ID:** NCT03003572
- **Lead sponsor:** Centre Hospitalier Universitaire de Saint Etienne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-03-27
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 185 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003572, "Autoreactive Anti-Ro/SSA IgE To Determine Primary SjögRen's Syndrome's Disease Activity". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03003572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*